Identification of TRIM14 as a Type I IFN-Stimulated Gene Controlling Hepatitis B Virus Replication by Targeting HBx

Hepatitis B virus (HBV) remains a major cause of hepatic disease that threatens human health worldwide. Type I IFN (IFN-I) therapy is an important therapeutic option for HBV patients. The antiviral effect of IFN is mainly mediated via upregulation of the expressions of the downstream IFN-stimulated...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Guangyun, Xu, Fengchao, Song, Hongxiao, Yuan, Ye, Xiao, Qingfei, Ma, Feng, Qin, F. Xiao-Feng, Cheng, Genhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100580/
https://www.ncbi.nlm.nih.gov/pubmed/30150992
http://dx.doi.org/10.3389/fimmu.2018.01872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100580/
https://www.ncbi.nlm.nih.gov/pubmed/30150992
http://dx.doi.org/10.3389/fimmu.2018.01872

Ejemplares similares